Closed sjspielman closed 2 years ago
Just wanted to note, these would be rerun after v22 for the cancer group updates, if any, to non-LGG, is that your thinking @sjspielman ?
@jharenza I don't think I realized that might happen. I was under the impression that LGG v22 changes would involve changing cancer groups, but not broad histologies, for LGG.
If which samples are in this broad histology might change, then we should NOT merge this, and I'll convert this back to draft and block it with v22 to re-run later.
I am hoping not, but upon QC of a new pull of the histologies file from our data warehouse, some path dx/free text have changed, and TBD whether this affects anything downstream. So probably safe to wait on this.
@jharenza This has now been re-run with V22. Some of the results have changed so please have a close look at those places where the notebook text has diffs.
I was wondering about the new Partial resection;Gross/Near total resection specimen! Will recode 👍
Will double check my text interpreting the table rows correctly!
@jharenza ready for another look!
This PR has previously passed CI, and changes have been smoothly run in a fresh RStudio session in Docker. Merging before checks complete.
Closes #1416
This PR updates and re-runs the two survival notebooks (tp53 and immune) that consider an LGG grouping. The grouping should be the
broad_histology
, NOT thecancer_group
. Results are broadly consistent.